CTRI/2024/05/067823
Not yet recruiting
未知
A Cross sectional Observational Study to Evaluate Predictive Value of Modified Mallampati Test Alone & in Conjunction with Voice Analysis for Difficult Laryngoscopy During General Anaesthesia - NI
KPC Medical College and Hospital0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: O- Medical and Surgical
- Sponsor
- KPC Medical College and Hospital
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Patients planned for elective Surgery under General Anaesthesia with tracheal intubation
- •2\.Patients with ASA Grade I and II
Exclusion Criteria
- •1\.Patients with ASA Grade III and IV
- •2\.Patient with a previous history of speech disorders,larengeal \& vocal cord diseases,
- •cleft palate, craniofacial syndromes, craniofacial trauma, previous oral and maxillofacial surgery,
- •3\.Patient with hearing or perception abnormalities, mental or central nervous system diseases,
- •4\.Pregnancy
- •5\.Patients refusing consent
- •6\.Patient admitted for emergency surgery.
- •7\.History of difficult laryngoscopy in past
- •8\.Patients participated in other relevant clinical investigation in the past 3 months
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Awareness and Adherence to Statin and Antiplatelet TherapyCTRI/2023/10/059075Seth GS Medical College KEM Hospital Diamond Jubilee Society Trust
Not yet recruiting
Not Applicable
Anti epileptic drugs and bone health - a cross sectional study of Indians with epilepsyCTRI/2024/03/064935itte Universisty Grant
Not yet recruiting
Not Applicable
A study to evaluate oral and dental needs in treated head and neck cancer survivor participantsCTRI/2024/05/067984Advanced Center for Cancer Treatment Research and Education in Cancer ACTREC Tata Memorial Center
Completed
Not Applicable
Study to assess the prevalence of chronic kidney disease in Type 2 Diabetes.CTRI/2015/05/005769AstraZeneca Pharma India Ltd3,000
Completed
Not Applicable
Study to assess the Prevalence of Heart Failure in Type 2 Diabetes Patients in IndiaHealth Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2019/08/020629AstraZeneca Pharma India Ltd621